Women's Perception of Respectful Maternity Care, Birth Experiences and Perception of Traumatic Birth
Launched by SELCUK UNIVERSITY · Nov 14, 2024
Trial Information
Current as of September 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific approach to maternity care, recommended by the World Health Organization (WHO), affects women's feelings about their childbirth experiences. The goal is to understand if this approach helps women feel more respected during labor and if it impacts their views on whether they experienced a traumatic birth.
To participate in this study, women must be at least 18 years old, in their final weeks of pregnancy (between 38 and 41 weeks), and having their first baby (primiparous) with a healthy single baby positioned head down. They should also be able to speak and understand Turkish and agree to join the study voluntarily. Women with serious health conditions or complications related to pregnancy or childbirth are not eligible. Participants can expect to share their thoughts and feelings about their birth experiences in a supportive environment. This research aims to improve maternity care by understanding women's perspectives better.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Those who are 18 years of age or older,
- • Those who are in term pregnancy (38-41 weeks),
- • Those who are primiparous,
- • Those who have a single, healthy, vertex positioned fetus,
- • Those who have cervical dilatation of 5 cm or more,
- • Those who can speak and understand Turkish,
- • Those who voluntarily agree to participate in the research.
- Exclusion Criteria:
- • Those with chronic diseases (hypertension, diabetes, etc.),
- • Those with a diagnosed mental illness (depression, anxiety or other psychotic disorder, etc.),
- • Those with maternal and fetal complications (oligohydramnios and polyhydramnios, placenta previa, preeclampsia, premature membrane rupture, presentation anomalies, intrauterine growth retardation, fetal anomalies, intrauterine death, macrosomic baby, cord prolapse, etc.),
- • Those with any complications that prevent vaginal birth (cephalopelvic disproportion, etc.),
- • Elective cesarean section,
- • Those who became pregnant with assisted reproductive techniques,
- • Those who received childbirth preparation training.
About Selcuk University
Selçuk University is a prominent educational institution located in Turkey, recognized for its commitment to advancing medical research and clinical studies. As a clinical trial sponsor, Selçuk University leverages its extensive academic resources and expertise to conduct innovative research that aims to address significant healthcare challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. Through rigorous adherence to ethical standards and regulatory guidelines, Selçuk University strives to contribute to scientific knowledge and enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, , Turkey
Patients applied
Trial Officials
Seyhan Çankaya, PhD
Principal Investigator
Selcuk University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported